Anti-CCR4 mAb selectively depletes effector-type FoxP3⁺CD4⁺ regulatory T cells, evoking antitumor immune responses in humans
Proceedings of the National Academy of Sciences - PNAS, 2013-10, Vol.110 (44), p.17945-17950 [Peer Reviewed Journal]copyright © 1993–2008 National Academy of Sciences of the United States of America ;Copyright National Academy of Sciences Oct 30, 2013 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1316796110 ;PMID: 24127572
Full text available